Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril Continuation vs Discontinuation in Coronary Angiography
NCT07184918Completed
- Sponsor
- Tanta University
- Start
- Feb 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ramipril in hypertension (HTN) (2 arms), sponsored by Tanta University. Primary endpoint: Change From Baseline in Serum Creatinine at 72 Hours Post-Angiography. Started Feb 2024; status: completed.
02
Drugs
ramipril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07184918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07184918.